Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors
Clinical trial NCT07292038 · RECRUITING
Trial details
- NCT number
- NCT07292038
- Sponsor
- NucMito Pharmaceuticals Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-18
- Primary completion
- 2026-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.